Search research articles
Contact Us
Filters
Showing results (161-170 of 175) with videos related to
Page
of 18
Sort By:
Journal of Clinical Pharmacy and Therapeutics
|
October 26, 2016
Cebranopadol: novel dual opioid/NOP receptor agonist analgesic
R B Raffa, G Burdge, J Gambrah, et al.
Epilepsia
|
March 1, 1994
Topiramate: preclinical evaluation of structurally novel anticonvulsant
R P Shank, J F Gardocki, J L Vaught, et al.
Journal of Clinical Pharmacy and Therapeutics
|
July 30, 2014
The clinical analgesic efficacy of buprenorphine
R B Raffa, M Haidery, H-M Huang, et al.
Journal of Clinical Pharmacy and Therapeutics
|
April 26, 2006
Is 'chemo-fog'/'chemo-brain' caused by cancer chemotherapy?
R B Raffa, P V Duong, J Finney, et al.
Journal of Medicinal Chemistry
|
February 7, 2001
Alpha(2) adrenoceptor agonists as potential analgesic agents. 2. Discovery of 4-(4-imidazo)-1,3-dimethyl-6,7-dihydro-thianaphthene as a high-affinity ligand for the alpha(2D) adrenergic receptor
T M Ross, M C Jetter, M E McDonnell, et al.
Journal of Clinical Pharmacy and Therapeutics
|
April 26, 2006
A potential novel strategy to separate therapeutic- and side-effects that are mediated via the same receptor: beta-arrestin2/G-protein coupling antagonists
I R Bruns, S Chhum, A T Dinh, et al.
Journal of Clinical Pharmacy and Therapeutics
|
June 2, 2016
Will peripherally restricted kappa-opioid receptor agonists (pKORAs) relieve pain with less opioid adverse effects and abuse potential?
A Albert-Vartanian, M R Boyd, A L Hall, et al.
Journal of Medicinal Chemistry
|
March 15, 2000
alpha(2) Adrenoceptor agonists as potential analgesic agents. 2. Discovery of 4-(4-Imidazo)-1,3-dimethyl-6,7-dihydrothianaphthene [corrected] as a high-affinity ligand for the alpha(2D) adrenergic receptor
T M Ross, M C Jetter, M E McDonnell, et al.
Journal of Medicinal Chemistry
|
April 13, 2001
Alpha(2) adrenoceptor agonists as potential analgesic agents. 3. Imidazolylmethylthiophenes
R E Boyd, J B Press, C R Rasmussen, et al.
Journal of Clinical Pharmacy and Therapeutics
|
May 11, 2007
The endocannabinoid system and rimonabant: a new drug with a novel mechanism of action involving cannabinoid CB1 receptor antagonism--or inverse agonism--as potential obesity treatment and other therapeutic use
S Xie, M A Furjanic, J J Ferrara, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 175) with videos related to
Sort By:
Page
of 18
Journal of Clinical Pharmacy and Therapeutics
|
October 26, 2016
Cebranopadol: novel dual opioid/NOP receptor agonist analgesic
R B Raffa, G Burdge, J Gambrah, et al.
Epilepsia
|
March 1, 1994
Topiramate: preclinical evaluation of structurally novel anticonvulsant
R P Shank, J F Gardocki, J L Vaught, et al.
Journal of Clinical Pharmacy and Therapeutics
|
July 30, 2014
The clinical analgesic efficacy of buprenorphine
R B Raffa, M Haidery, H-M Huang, et al.
Journal of Clinical Pharmacy and Therapeutics
|
April 26, 2006
Is 'chemo-fog'/'chemo-brain' caused by cancer chemotherapy?
R B Raffa, P V Duong, J Finney, et al.
Journal of Medicinal Chemistry
|
February 7, 2001
Alpha(2) adrenoceptor agonists as potential analgesic agents. 2. Discovery of 4-(4-imidazo)-1,3-dimethyl-6,7-dihydro-thianaphthene as a high-affinity ligand for the alpha(2D) adrenergic receptor
T M Ross, M C Jetter, M E McDonnell, et al.
Journal of Clinical Pharmacy and Therapeutics
|
April 26, 2006
A potential novel strategy to separate therapeutic- and side-effects that are mediated via the same receptor: beta-arrestin2/G-protein coupling antagonists
I R Bruns, S Chhum, A T Dinh, et al.
Journal of Clinical Pharmacy and Therapeutics
|
June 2, 2016
Will peripherally restricted kappa-opioid receptor agonists (pKORAs) relieve pain with less opioid adverse effects and abuse potential?
A Albert-Vartanian, M R Boyd, A L Hall, et al.
Journal of Medicinal Chemistry
|
March 15, 2000
alpha(2) Adrenoceptor agonists as potential analgesic agents. 2. Discovery of 4-(4-Imidazo)-1,3-dimethyl-6,7-dihydrothianaphthene [corrected] as a high-affinity ligand for the alpha(2D) adrenergic receptor
T M Ross, M C Jetter, M E McDonnell, et al.
Journal of Medicinal Chemistry
|
April 13, 2001
Alpha(2) adrenoceptor agonists as potential analgesic agents. 3. Imidazolylmethylthiophenes
R E Boyd, J B Press, C R Rasmussen, et al.
Journal of Clinical Pharmacy and Therapeutics
|
May 11, 2007
The endocannabinoid system and rimonabant: a new drug with a novel mechanism of action involving cannabinoid CB1 receptor antagonism--or inverse agonism--as potential obesity treatment and other therapeutic use
S Xie, M A Furjanic, J J Ferrara, et al.
Page
of 18